Sanoculis Receives CE Mark for MINT® Product for the Treatment of Glaucoma

Contributed by: PR Newswire

Tags

Sanoculis-CE-Mark

More Like This

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

PR Newswire associated0

ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser

PR Newswire associated0

ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

PR Newswire associated0

NTC gives long term consistency to its ophtha portfolio with another MDR CE Certificate approval

PR Newswire associated0

NTC Ophthalmics lberica: Young ophthalmologists square in Zahara Los Atunes

PR Newswire associated0

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025

PR Newswire associated0

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING

SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS